Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination
Go back to Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination| Xenetic Biosciences, Inc. (NASDAQ: XBIO) | Delayed: 2.94 +0.14 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $5.20 | |||
| Open | $2.76 | 52 Week Low | $0.21 | |||
| Day High | $2.94 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $-0.01 | |||
| Volume | 11,254 | |||||
